201. ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression
- Author
-
Fangyu Zhao, Ming Yao, Chao Ge, Liangyu Li, Cong Chen, Hua Tian, Jinjun Li, Hong Li, Taoyang Chen, and Zheng Liu
- Subjects
Male ,0301 basic medicine ,Cancer Research ,Carcinoma, Hepatocellular ,Hepatocellular carcinoma ,Activating transcription factor ,Biology ,Transfection ,medicine.disease_cause ,lcsh:RC254-282 ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Cell Movement ,Cell Line, Tumor ,medicine ,Transcriptional regulation ,Animals ,Humans ,ATF3 ,Transcription factor ,Cell Proliferation ,Reporter gene ,Activating Transcription Factor 3 ,Sequence Analysis, RNA ,Research ,Liver Neoplasms ,CYR61 ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,digestive system diseases ,Up-Regulation ,Gene Expression Regulation, Neoplastic ,030104 developmental biology ,Oncology ,Tissue Array Analysis ,030220 oncology & carcinogenesis ,Cancer cell ,Disease Progression ,Cancer research ,Female ,Transcription Initiation Site ,Carcinogenesis ,Chromatin immunoprecipitation ,Neoplasm Transplantation ,Cysteine-Rich Protein 61 - Abstract
Background Hepatocellular carcinoma (HCC) is one of the most common malignant cancers with a high incidence and high mortality in East Asia. Identifying biomarkers and clarifying the regulatory mechanisms of HCC are of great importance. Herein, we report the role and mechanism of activating transcription factor 3 (ATF3), a member of the ATF/cAMP-responsive element-binding protein family of transcription factors in HCC. Methods ATF3 overexpression vector and shRNAs were transfected into HCC cancer cells to upregulate or downregulate ATF3 expression. In vitro and in vivo assays were performed to investigate the functional role of ATF3 in hepatocellular carcinoma. RNA-Seq was performed to screen the differentially expressed genes downstream of ATF3. The dual-luciferase reporter assay, chromatin immunoprecipitation (Ch-IP) analysis and functional rescue experiments were used to confirm the target gene regulated by ATF3. Tissue microarrays (TMAs) comprising 236 human primary HCC tissues were obtained and immunohistochemical staining were carried out to analyze the clinical significance of ATF3. Results The results indicate that ATF3 significantly inhibited the proliferation and mobility of HCC cells both in vitro and in vivo. Cysteine-rich angiogenic inducer 61 (CYR61) is a key target for transcriptional regulation by ATF3. Both ATF3 and CYR61 were consistently downregulated in human HCC tissues, and their expression levels were significantly and positively correlated with each other. Conclusions Our findings indicate that ATF3 functions as a tumor suppressor in HCC through targeting and regulating CYR61. Electronic supplementary material The online version of this article (10.1186/s13046-018-0919-8) contains supplementary material, which is available to authorized users.
- Published
- 2018